AKZA:EURONEXT AMSTERDAMAkzo Nobel N.V. Analysis

Akzo Nobel shares are trading at €51.36, well below the 20‑day (≈€56.8), 50‑day (≈€58.3) and 200‑day (≈€58.4) simple moving averages, signalling a pronounced bearish trend. The RSI sits at 27.9, indicating oversold conditions, while the MACD line remains beneath its signal, reinforcing short‑term downside momentum. Volume is rising, but price has stalled above the nearest support at €50.54 and faces resistance near €61.88, suggesting limited upside in the near term.
Fundamentally, revenue has contracted 9.4% YoY and the company carries a high debt‑to‑equity ratio of roughly 101%, yet it generates solid cash flow (≈€918 M free cash) and sustains a generous 3.78% dividend yield with a payout ratio just above 50%, implying dividend sustainability. Valuation metrics show a forward P/E of 11.3 and a DCF‑derived fair value of €55.7, both below analyst consensus targets around €68, indicating the stock is undervalued relative to its intrinsic potential. Recent news of a Q4 earnings miss and a muted 2026 outlook triggered a 4% price drop, adding short‑term pressure despite the attractive dividend and long‑term recovery prospects in the specialty chemicals sector.